Home \ Expert Opinion \ Stroke in the Covid-19 era

Stroke in the Covid-19 era

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

01:11
Statistics on the incidence of stroke
02:00
The effect of Covid infection on the mortality from stroke
03:07
Stroke pathogenesis in patients with COVID-19
04:35
Stroke help structure with a stroke
06:00
Diagnostic minimum and hospitalization
07:15
Differential diagnosis and enhanced attention to diagnosis
09:28
Differences in clinical recommendations
10:13
Primary and secondary neurocytoprotext and criteria for the choice of drugs
14:01
Evidence base of neurocytoprotective therapy
16:00
The effectiveness of the drug Mexidol® based on the results of an epic study

Ekusheva Evgenia Viktorovna - MD, professor, head. Department of Nervous Diseases and Neurorebition of the Academy of Postgraduate Education of the Federal State Budgetary Educational Institution of the FGBC FMBA of Russia

Schukin Ivan Aleksandrovich - Ph.D., Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics LF RNIMU named after N.I. Pirogov

Announcement:

During the pandemic Covid-19, the mortality of the stroke increased. The development of a stroke in patients with Covid-19 may be associated with various risk factors such as arterial hypertension and atherosclerosis. The virus can also lead to a cytokine storm and a systemic inflammatory response, which contributes to the development of ischemic stroke. Hemorrhagic stroke is more often associated with Covid-associated coagulopathy and erythrocyte hemolysis. Patients with a stroke who suffered Covid-19 often need constant help in everyday life. The structure of assistance to these patients has not changed, but new clinical methods were developed to conduct these patients. The intake of Mexidol® after coronavirus has the following effects: membrane, antihypoxic, antioxidant, etc. Read more about the effects, as well as taking the drug Mexidol® after a stroke and therapy after Covid-19 in our video.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

01:11
Statistics on the incidence of stroke
02:00
The effect of Covid infection on the mortality from stroke
03:07
Stroke pathogenesis in patients with COVID-19
04:35
Stroke help structure with a stroke
06:00
Diagnostic minimum and hospitalization
07:15
Differential diagnosis and enhanced attention to diagnosis
09:28
Differences in clinical recommendations
10:13
Primary and secondary neurocytoprotext and criteria for the choice of drugs
14:01
Evidence base of neurocytoprotective therapy
16:00
The effectiveness of the drug Mexidol® based on the results of an epic study

Block of articles on this topic

Study of the effectiveness and safety of the drug Mexol Fort 250 as part of consecutive therapy in patients with a hemisphere ischemic stroke in acute and early recovery periods

Authors:
M.A. Loskutnikov, M.A. Domashenko, T.M. Vakin, I.A. Trushina, V.I. Konstantinov, O.S. Proskuryakova, E.P. Schukina

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. Rakhimbayeva, Sh.R. Gazieva, M.K. Atyaniyazov, F.Kh. Muratov, D.S. Tolipov, U.D. Shodiev

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Asthenia and cognitive disorders against the background of the transformed infections of the Covid-19: possible correction routes

Author:
Ostroumova T.M.

FGAOU in "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

The role of antioxidant therapy in patients with the new coronavirus infection of the Covid-19 of the Motenza and Severe

Authors:
E.K. Shavarova ^1.2 , E.R. Kazamedov ¹ , M.V. Alekseeva ¹ , L.G. Yezhova ² , railway Cobalava ¹

¹ Russian University of Friendship of Peoples (RUDN), Moscow, Russian Federation;
² City Clinical Hospital named after V.V. Vinogradov Department of Health of the city of Moscow, Moscow, Russian Federation

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in the restoration treatment of patients who have undergone ischemic stroke

Authors:
M.V. Zhuravlev ^1.2 , A.B. Prokofiev ^1.2 , V.V. Arkhipov ¹ , S.Yu. Serebrova ^1.2 , G.I. Gorodetskaya ^1.2 , O.A. Demidova ¹

¹ FSBI “Scientific Center for Expertise of Medical Application” of the Ministry of Health of Russia, Moscow, Russia;
² FGAOU VO "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com